Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna.

Recruiting Observational Study
Palliative Care
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
7,000 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the study is to assess the outcome in palliative patients, particularly in terms of symptom resolution or alleviation, after radiation treatment of the various tumours analysed, in relation to the treatment setting, dosages and techniques used both for newly diagnosed tumours and for cases already diagnosed and treated at the Radiotherapy Unit of the Sant Orsola Hospital.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * adult patients of either sex with a new or previous diagnosis of malignant neoplasm since 1st January 2000 * patients treated with paliative radiotherapy * obtaining of informed consent Exclusion Criteria: * adult patients of either sex with a new or previous diagnosis of ma…
Contacts

Alessio Giuseppe Morganti, MD

0512143564

alessio.morganti2@unibo.it

CONTACT

Costanza Maria Donati, MD

costanzamaria.donati@unibo.it

CONTACT